If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRAV.L Regulatory News (RAV)

  • There is currently no data for RAV

Rule 8.3- Raven Russia Ltd

23 Apr 2009 16:43

RNS Number : 0784R
Cheyne Capital Management (UK) LLP
23 April 2009
 



  FORM 8.3

DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE 

(Rule 8.3 of the Takeover Code)

1. KEY INFORMATION

Name of person dealing  (Note 1)

Cheyne Capital Management (UK) LLP

Company dealt in

Raven Russia Ltd

Class of relevant security to which the dealings being disclosed relate (Note 2)

Ordinary

Date of dealing

23rd April 2009

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Long

Short

Number (%)

Number (%)

(1) Relevant securities 

0 0

0 0

(2) Derivatives (other than options) - CFD

0   0

0 0

(3) Options and agreements to purchase/sell

0 0

0 0

Total

0 0

0 0

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

Number (%)

Number (%)

(1) Relevant securities 

0 0

0 0

(2) Derivatives (other than options)

0 0

0 0

(3) Options and agreements to purchase/sell

0 0

0 0

Total

0 0

0 0

(c) Rights to subscribe (Note 3)

Class of relevant security:

Details

3. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale

Number of securities

Price per unit (Note 5)

(b) Derivatives transactions (other than options)

Product name, 

e.g. CFD

Long/short (Note 6)

Number of securities (Note 7)

Price per unit (Note 5)

CFD

Short

18,942,752

GBp 19.46

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise

price 

Type, e.g. American, European etc.

Expiry 

date

Option money

paid/received per unit (Note 5) 

(ii) Exercising

Product name, e.g. call option

Number of securities 

Exercise price per unit (Note 5)

(d) Other dealings (including new securities) (Note 4)

Nature of transaction (Note 8)

Details

Price per unit (if applicable) (Note 5)

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 attached? (Note 9) NO

Date of disclosure

23rd April 2009

Contact name

Kiran Bassi

Telephone number

020 7968 7324

If a connected EFM, name of offeree/offeror with which connected

If a connected EFM, state nature of connection (Note 10)

Notes

The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETEXLFLKZBZBBF
Date   Source Headline
5th Jun 20207:00 amRNSNotice of AGM and Posting of Annual Report
28th May 20207:00 amRNSConvertible Preference Share Dividend (RAVC)
22nd May 20207:00 amRNSDisclosure of Rights Attached to Listed Securities
21st May 20207:00 amRNSScrip Dividend Circular (RAVP)
6th May 20207:00 amRNSPreference Share Dividend (RAVP)
23rd Apr 202012:45 pmRNSRe-Designation of Convertible Preference Shares
1st Apr 20207:00 amRNSTotal Voting Rights
30th Mar 20207:00 amRNSIssue of Preference Shares (RAVP)
17th Mar 20205:30 pmRNSDirector/PDMR Shareholding
16th Mar 20207:00 amRNSFinal Results
11th Mar 20204:30 pmRNSTransaction in Own Shares
27th Feb 20207:00 amRNSConvertible Preference Share Dividend (RAVC)
20th Feb 20207:00 amRNSScrip Dividend Circular (RAVP)
20th Feb 20207:00 amRNSScrip Dividend Circular (RAVP)
13th Feb 20206:00 pmRNSTransaction in Own Shares
6th Feb 20207:00 amRNSPreference Share Dividend (RAVP)
3rd Feb 20207:00 amRNSBlock Listing cancellation and six monthly return
2nd Jan 20207:00 amRNSTotal Voting Rights
31st Dec 201912:15 pmRNSDirector/PDMR Shareholding
30th Dec 20197:00 amRNSIssue of Preference Shares (RAVP)
12th Dec 201911:48 amRNSTransaction in Own Shares
11th Dec 20197:00 amRNSTransaction in Own Shares
10th Dec 20197:00 amRNSHolding(s) in Company
2nd Dec 20195:00 pmRNSTransaction in Own Shares
2nd Dec 201911:30 amRNSTransaction in Own Shares
28th Nov 20197:00 amRNSConvertible Preference Share Dividend (RAVC)
21st Nov 20193:00 pmRNSDirector/PDMR Shareholding
21st Nov 20197:00 amRNSScrip Dividend Circular (RAVP)
19th Nov 201912:00 pmRNSHolding(s) in Company
11th Nov 20197:00 amRNSTotal Voting Rights
8th Nov 20193:44 pmRNSResult of General Meeting and Tender Offer
7th Nov 20197:00 amRNSPreference Share Dividend (RAVP)
6th Nov 20193:00 pmRNSDirector/PDMR Shareholding
29th Oct 20194:30 pmRNSHolding(s) in Company
28th Oct 20197:00 amRNSAnnouncement of Tender Offer price in Rand
25th Oct 20194:50 pmRNSTransaction in Own Shares
17th Oct 20193:00 pmRNSDirector/PDMR Shareholding
9th Oct 20194:35 pmRNSPrice Monitoring Extension
9th Oct 20193:00 pmRNSTender Offer and Notice of GM
1st Oct 20197:00 amRNSTotal Voting Rights
27th Sep 20197:00 amRNSIssue of New Preference Shares (RAVP)
12th Sep 20196:00 pmRNSHolding(s) in Company
4th Sep 20196:00 pmRNSHolding(s) in Company
2nd Sep 20194:50 pmRNSDirector/PDMR Shareholding
2nd Sep 20197:00 amRNSTotal Voting Rights
29th Aug 20197:00 amRNSConvertible Preference Share Dividend (RAVC)
27th Aug 20197:00 amRNSHalf-year Report
23rd Aug 20199:00 amRNSHolding(s) in Company
22nd Aug 20197:00 amRNSScrip Dividend Circular (RAVP)
21st Aug 20194:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.